Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 2

Session: HIV State of the Art: On the Horizon

Gender Differences in PrEP Efficacy and Uptake

Friday, October 1, 2021
4:15 PM - 5:30 PM EDT
Participants should be aware of the following financial/non-financial relationships:
Latesha Elopre, MD: Merck/MSD (Individual(s) Involved: Self): Grant/Research Support, Phase III Clinical Trial for long-acting PrEP among cis-gender women.

    Speaker(s)

  • Latesha Elopre, MD

    Assistant Professor of Medicines
    University of Alabama
    Birmingham, AL, United States

    Merck/MSD (Individual(s) Involved: Self): Grant/Research Support, Phase III Clinical Trial for long-acting PrEP among cis-gender women.